Pengyu Zhang
Hubei University of Medicine(CN)University of Wisconsin–Madison(US)Central South University(CN)Peking University(CN)Tianjin Medical University Cancer Institute and Hospital(CN)China National Pharmaceutical Group Corporation (China)(CN)First Hospital of China Medical University(CN)Dongfeng General Hospital(CN)South University(US)Jeonbuk National University(KR)China Medical University(CN)
Publications by Year
Research Areas
Asthma and respiratory diseases, Blood Pressure and Hypertension Studies, Platelet Disorders and Treatments, Functional Brain Connectivity Studies, Cardiac Health and Mental Health
Most-Cited Works
- → Fucoidan and galactooligosaccharides ameliorate high-fat diet–induced dyslipidemia in rats by modulating the gut microbiota and bile acid metabolism(2019)149 cited
- → Prognostic value of pretreatment serum lactate dehydrogenase level in patients with solid tumors: a systematic review and meta-analysis(2015)134 cited
- → Effectiveness of a non-physician community health-care provider-led intensive blood pressure intervention versus usual care on cardiovascular disease (CRHCP): an open-label, blinded-endpoint, cluster-randomised trial(2023)127 cited
- → Effects of intermittent fasting diets on plasma concentrations of inflammatory biomarkers: A systematic review and meta-analysis of randomized controlled trials(2020)97 cited
- → Tumor markers CA15-3, CA125, CEA and breast cancer survival by molecular subtype: a cohort study(2020)92 cited
- → Fucoidan alleviates dyslipidemia and modulates gut microbiota in high-fat diet-induced mice